Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Desert Gold Report Results from 3,900 Meter Phase 2 Exploration Drill Program (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Charles River Laboratories International Inc CRL

Technology Scientific & Technical Instruments
Charles River Laboratories International, Inc. provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. The Company's Research Models and Services segment is comprised of three businesses that provide foundational tools that enables its... see more

Recent & Breaking News (NYSE:CRL)

Carl Data Solutions Completes U.S. Listing with OTC Markets

MarketWire Canada September 28, 2016

Charles River Laboratories and The Tri-Insitutional Therapeutics Discovery Institute Announce Strategic Partnership

Business Wire September 22, 2016

Charles River Laboratories to Present at September Investor Conferences

Business Wire September 6, 2016

Charles River Laboratories Announces Partnership with the Milner Therapeutics Institute and Consortium

Business Wire August 8, 2016

Charles River Laboratories Announces Second-Quarter 2016 Results from Continuing Operations

Business Wire August 3, 2016

Director / PDMR Shareholding

UK Regulatory news services, from the LSE July 21, 2016

Election of Home Member State

UK Regulatory news services, from the LSE July 21, 2016

Result of AGM

UK Regulatory news services, from the LSE July 21, 2016

Holding(s) in Company

UK Regulatory news services, from the LSE July 21, 2016

Net Asset Value(s)

UK Regulatory news services, from the LSE July 21, 2016

Charles River Laboratories Schedules Second-Quarter 2016 Earnings Release and Conference Call

Business Wire July 11, 2016

Daimler EUR 1bn 2021 Post Stabilisation Notice

UK Regulatory news services, from the LSE June 29, 2016

Form 8.3 - Premier Farnell Plc

UK Regulatory news services, from the LSE June 29, 2016

Annual Report and Notice of AGM

UK Regulatory news services, from the LSE June 29, 2016

Final Results

UK Regulatory news services, from the LSE June 28, 2016

Transaction in Own Shares

UK Regulatory news services, from the LSE June 28, 2016

Net Asset Value(s)

UK Regulatory news services, from the BW June 28, 2016

Charles River Laboratories Acquires Blue Stream Laboratories

Business Wire June 27, 2016

Charles River Laboratories to Present at Jefferies and William Blair Conferences

Business Wire June 6, 2016

Moderna Therapeutics and Charles River Laboratories Announce Strategic Collaboration to Scale Moderna’s Nonclinical Development Efforts for Novel mRNA Therapeutics

Business Wire June 6, 2016